Search Orphan Drug Designations and Approvals
-
Generic Name: | nipocalimab |
---|---|
Date Designated: | 10/14/2021 |
Orphan Designation: | Treatment of chronic inflammatory demyelinating polyneuropathy |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Janssen Research & Development, LLC 1125 Trenton-Harbourton Road Titusville, New Jersey 08560 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-